285 related articles for article (PubMed ID: 2693618)
21. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
22. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.
Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069
[TBL] [Abstract][Full Text] [Related]
23. Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.
Voit T; Haas K; Léger JO; Pons F; Léger JJ
Am J Pathol; 1991 Nov; 139(5):969-76. PubMed ID: 1951635
[TBL] [Abstract][Full Text] [Related]
24. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
Wang X; Xie Y; Zhang C; Liu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
Ikeya K; Saito K; Yamauchi A; Kondo E; Komine S; Ikenaka H; Mishima M; Takahashi R; Harada T; Fukuyama Y
No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
[TBL] [Abstract][Full Text] [Related]
26. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.
Bonilla E; Schmidt B; Samitt CE; Miranda AF; Hays AP; de Oliveira AB; Chang HW; Servidei S; Ricci E; Younger DS
Am J Pathol; 1988 Dec; 133(3):440-5. PubMed ID: 3059802
[TBL] [Abstract][Full Text] [Related]
27. Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry.
Oliveira AS; Gabbai AA; Schmidt B; Kiyomoto BH; Lima JG; Minetti C; Bonilla E
Arq Neuropsiquiatr; 1992 Dec; 50(4):478-85. PubMed ID: 1309152
[TBL] [Abstract][Full Text] [Related]
28. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
Nicholson LV
Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
[TBL] [Abstract][Full Text] [Related]
29. Unraveling the mysteries of Duchenne and Becker muscular dystrophy.
Hyser CL
Mol Chem Neuropathol; 1989 Feb; 10(1):15-20. PubMed ID: 2660836
[TBL] [Abstract][Full Text] [Related]
30. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
[TBL] [Abstract][Full Text] [Related]
31. Quantitative and qualitative alterations of dystrophin are expressed in muscle cell cultures of Xp21 muscular dystrophy patients (Duchenne and Becker type).
Mongini T; Doriguzzi C; Palmucci L; Chiadò-Piat L
Eur J Clin Invest; 1996 Apr; 26(4):322-4. PubMed ID: 8732491
[TBL] [Abstract][Full Text] [Related]
32. [Detection of dystrophin with anti-peptide antibodies].
Takeda A; Jimi T; Misugi N; Miyake S; Kumagai T; Nakamura Y; Wakayama Y
Rinsho Byori; 1992 Sep; 40(9):953-8. PubMed ID: 1434031
[TBL] [Abstract][Full Text] [Related]
33. Prediction of dystrophin phenotype by DNA analysis in Duchenne/Becker muscular dystrophy.
Specht LA; Beggs AH; Korf B; Kunkel LM; Shapiro F
Pediatr Neurol; 1992; 8(6):432-6. PubMed ID: 1476571
[TBL] [Abstract][Full Text] [Related]
34. Absence of dystrophin in two patients with Becker type Xp21 muscular dystrophy.
Mongini T; Palmucci L; Doriguzzi C; Chiadoò-Piat L; Restagno G
Neurosci Lett; 1992 Nov; 147(1):37-40. PubMed ID: 1480320
[TBL] [Abstract][Full Text] [Related]
35. Dystrophin-positive myotubes in innervated muscle cultures from Duchenne and Becker muscular dystrophy patients.
Fanin M; Hoffman EP; Saad FA; Martinuzzi A; Danieli GA; Angelini C
Neuromuscul Disord; 1993 Mar; 3(2):119-27. PubMed ID: 8358237
[TBL] [Abstract][Full Text] [Related]
36. Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy.
Haginoya K; Yamamoto K; Iinuma K; Yanagisawa T; Ichinohasama Y; Shimmoto M; Suzuki Y; Tada K
J Neurol; 1991 Oct; 238(7):375-8. PubMed ID: 1683669
[TBL] [Abstract][Full Text] [Related]
37. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin.
Matsumura K; Burghes AH; Mora M; Tomé FM; Morandi L; Cornello F; Leturcq F; Jeanpierre M; Kaplan JC; Reinert P
J Clin Invest; 1994 Jan; 93(1):99-105. PubMed ID: 8282827
[TBL] [Abstract][Full Text] [Related]
39. Dystrophin assay in muscular dystrophies: an Indian experience.
Jain S; Sarkar C; Dinda AK; Maheshwari MC
Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930
[TBL] [Abstract][Full Text] [Related]
40. Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins.
Mora M; Morandi L; Piccinelli A; Gussoni E; Gebbia M; Blasevich F; Dworzak F; Cornelio F
J Neurol; 1993 Sep; 240(8):455-61. PubMed ID: 8263549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
